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Background/aim : Advanced chronic periodontitis is observed rarely in acromegaly. Periodontal tissue including the alveolar bone
is seemed to be spared from the systemic metabolic derangements of bone in this patient population. Chronic elevation of growth
hormone, IGF-1, and bone morphogenetic proteins may play a role in periodontal tissue regeneration in acromegalics. In this study, we
aimed to evaluate the potential roles of local gingival bone morphogenetic proteins (BMP) in periodontal tissue pathology in acromegaly.
Materials and methods: Thirty-five patients with acromegaly and 22 healthy subjects were recruited. All the participants were examined
by the same periodontologist for the diagnosis of periodontal diseases. BMP-2 and -4 were studied in gingival crevicular fluid.
Results: Gingival BMP-2 and BMP-4 levels were similar in acromegaly and control groups in general, with and without chronic
periodontitis. For all the participants, gingival BMP-2 levels were statistically lower in those participants with chronic periodontitis
then those without periodontitis (29.4 ± 11.2 vs. 41.2 ± 23.2, respectively, p = 0.027). Causal relation between the gingival BMP levels
and periodontal tissue health status was tested with one way ANOVA which revealed a significant difference between gingival BMP2 levels in those with different degrees of periodontal tissue pathology (p = 0.025). When analyzed separately, gingival BMP-2 levels
revealed a causal relation with the degree of periodontal pathology with borderline significance only in patients with acromegaly (p =
0.057).
Conclusion: Acromegaly is a disease with an unexpectedly low frequency of advanced periodontitis, irrespective of the long disease
duration and pathognomonic oral manifestations. BMP-2 might have a protective role against chronic advanced periodontitis in these
patients.
Key words: Acromegaly, periodontitis, growth hormone, bone morphogenetic protein-2, bone morphogenetic protein-4

1. Introduction:
Acromegaly is among the rare diseases with complex
effects on bone remodelling. Uncontrolled secretion of
growth hormone (GH) from the hypophysis is the key
feature of acromegaly, whereas elevated levels of insulinlike growth factor-1 (IGF-1), insulin-like growth factor
binding protein-3 and calcitriol, and the presence or
absence of secondary gonadal insufficiency are important
factors that influence the bone metabolism in these
patients (1). Duration of disease activity and remission are
also important determinants of the final bone health (2).
Acromegaly has important pathognomonic oral
features of prognathism, macroglossia, increased
interdental spaces, and dental mobility (3). Although its
typical characteristics are well known, periodonditis is

unexpectedly rare, as demonstrated in some of the recent
studies (4,5). Likewise in our previous study, we found
that chronic periodontitis was not encountered more
frequently, then the age and sex matched population
and even surprisingly the advanced from of it was less
commonly observed in acromegalic patients (6).
Alveolar bone metabolism and thus, periodontal
tissue seems to be spared or less affected by the complex
influencing factors in acromegaly. Growth factors like
GH, IGF-1, and GH-mediated local growth factors like
bone morphogenetic proteins (BMPs) may play roles in
periodontal tissue regeneration in this patient population.
GH and IGF-1 are known to increase the formation of
bone and hard tissues of the tooth (dentine, cementum,
and enamel) (7). GH receptors are expressed in these
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tissues and can mediate local growth responses. There
are few reports demonstrating the stimulation of bone
morphogenetic protein-2 and -4 mRNA expression by
GH and IGF-1 up to 4- to 5-fold in human dental pulp
fibroblasts in vitro (8). BMP play an important role in
periodontal tissue regeneration both in fetal life and in
adults (9). The therapeutic use of recombinant BMPs
like recombinant human (rh) BMP-2 has attracted
considerable interest in the treatment of various
periodontal diseases due to the potent ability of these
factors to stimulate intramembranous bone formation
without an endochondral intermediate (10).
In our present study, we hypothesized that the excess
of GH/IGF-1 affects directly or indirectly the bone
remodelling of the periodontal tissue in acromegaly
patients. Long-standing GH/IGF-1 excess, by increasing
the local tissue BMP levels, might influence positively
the regenerative capacity of the periodontal tissue in this
patient group. In this context, we aimed to determine
BMP-2 and BMP-4 levels in the gingival fluid to find any
association with the health status of the periodontal tissue
in those with acromegaly.
2. Materials and methods
2.1. Study Subjects
We enrolled 35 acromegalic patients from the outpatient
clinic of the Endocrinology Department at Başkent
University Faculty of Medicine, consequently, between
September 2010 and July 2013. The diagnosis of
acromegaly was established clinically and confirmed by
high serum GH concentrations that were not suppressed
after oral glucose tolerance test (75 gr), elevated IGF-1
levels for age and sex, and demonstration of the pituitary
tumor by computed tomographic scan or magnetic
resonance imaging. Duration of the disease, history of
pituitary surgery and radiotherapy, activity of the disease,
treatment with a somatostatin analogue, and length of
remission were recorded. A total of 22 otherwise healthy
participants were enrolled for oral examination to assess
periodontal tissue health and gingival BMP measurement.
Exclusion criteria were history of chronic renal failure,
hyperparathyroidism, hyperthyroidism, and active
smoking, which may all influence bone metabolism and
periodontal tissue. Informed written consent was obtained
from all subjects prior to their enrollment, and our local
ethics committee approved the study protocol (tracking
number KA08/104).
2.2. Periodontal assesment
Individuals from both groups were asked to fill a
questionnaire about oral hygiene and frequency of annual
check-up and/or regular dental visits.
All of the study subjects were examined by the same
experienced periodontist. Periodontal pocket depth

(presence of an abnormal gingival sulcus near the point
at which the gums contact a tooth) was evaluated using
periodontal probe at six different points of each tooth.
Individuals with probing pocket depth (PPD) between
4-6 mm and clinical attachment level (CAL= amount of
space between attached periodontal tissues and a fixed
point, usually the cementoenamel junction) up to 4 mm
were considered aschronic periodontitis with slight to
moderate loss of periodontal support [15]. Those with
PPD ≥ 6 mm and CAL greater than 4 mm were considered
as chronic periodontitis with advanced loss of periodontal
support (16). Bleeding on probing, which was considered
an objective inflammatory parameter in periodontitis
establishment, was measured using gingival bleeding index
(GBI) (17). Gingival bleeding index ≤0.1 was considered
as low risk for the development of periodontitis. Tooth
mobility levels were evaluated and classified as degrees 1,
2, and 3. Radiographic examinations, tooth loss, diastemas
(space or gap between two teeth), and malocclusion were
also assessed.
2.3. Endocrinological assesment
Clinical data of acromegalic patients were evaluated and
assessed by the same experienced endocrinologist.
The estimated duration of the disease was determined
according to the clinical history and review of the past
photographs of the patients. The disease activity was
assessed by GH suppression during OGTT. Hormonal
status of anterior hypophysis was analysed by both basal
serum pituitary hormone levels (ACTH, PRL, FSH, LH,
TSH) with their end organ hormones and dynamic tests.
Disease was considered cured when all these criteria were
met: Random GH level less than 2.5 mg/L, plasma IGF-1
levels normal for the patient’s age, GH suppressed during
OGTT, and the patient is not taking any somatostatine
analog. Disease was defined as inactive when random GH
level was less than 2.5 mg/L, and plasma IGF-1 levels were
normal for the patient’s age under a somatostatin analog.
2.4. Biochemical assesment
Serum levels of GH, IGF-1, and IGFBP-3 were determined
by commercially available kits: chemiluminescent
enzyme immunometric assay for GH (Immulite
Growth Hormone, Diagnostic Products Corp., CA,
USA), immunoradiometric assay (Diagnostic Systems
Laboratories, DSL-6600 ACTIVE) for IGFBP-3, highly
sensitive and specific immunoradiometric assay, which
uses a modified version of the standard acid-ethanol
extraction procedure (Diagnostic Systems Laboratories,
DSL-5600 ACTIVE) for plasma IGF-1.
The levels of BMP-2, and -4 in GCF samples were assayed
using sandwich ELISA method (Aviscera Bioscience
Inc., Santa Clara, CA, USA). All ELISA procedures were
carried out according to the manufacturer’s instructions.
Microcentrifuge tubes, containing a PerioPaper strip,
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with absorbed Gingival cevicular fluid (GCF) sample,
were removed from storage and warmed to +4 °C, and
then eluted using a centrifuge (11). The microcentrifuge
tubes containing the strips and the dilution buffer were
vortexed for 1 min and incubated overnight at +4 °C.
The next morning, samples were vortexed for 3 min at
room temperature. After the centrifugation at 1000 g 20
min, the strips were removed and the fluid was assayed by
ELISA for BMP-2 and BMP-4. The ELISA plates were then
assessed spectrophotometrically for their optical density
(OD) at an absorbance of 450 nm. The levels of BMP-2
and BMP-4 in in each GCF sample were determined using
the concentration values of the standards included in the
kit. The detection limits were as follows; BMP2 < 46.87
pg/mL, BMP-4 < 3.9 pg/mL. The intra- and inter-assay
variabilities were 4%–6% and 8%–12% for BMP-2 and
BMP-4, respectively.
Statistical analysis: Descriptive statistics for the study
group are expressed as mean ± standard deviation for
continuous variables and as proportions for ordinal
(categoric) variables, such as sex, radiotherapy, presence
of periodondititis, and malocclusion. Differences
within patient clinical characteristics, BMP levels, and
comparisons with the healthy control group were evaluated
for statistical significance using the Student’s t-test and the
Chi-square method where appropriate. Comparison of
nonparametric groups (acromegaly disease duration) was
analysed by using Mann–Whitney U test. Assumption of
equal group variances for continuous variables were tested

by Levene’s tets for Students t- test. To test the effect of
gingival BMP levels on the severity of periodontal disease,
one way ANOVA test was conducted. Assumption of
equal group variances was tested by posthoc Bonferroni
and Dunnett tests. Statistical significance was considered
when a two-sided p value was 0.05 or below. For statistical
analysis, Predictive Analytics Software (PASW-Release 18)
statistical software was used.
3. Results:
A total of 35 acromegalic patients with a mean age
of 46.7 ± 10.2 years, and 22 otherwise healthy control
volunteers with a mean age of 42.4 ± 4.2 years were
included in the study. All of the acromegalic patients
underwent pituitary surgery and 15 patients received
radiotherapy. Twenty-nine of the acromegalic patients
were under somatostatin analog treatment. Twelve of the
acromegalic patients had inactive or cured disease, 23
patients had active disease. There was only one patient
whose disease was cured.
The clinical characteristics and the gingival BMP
levels of the study participants are given in Table 1.
The acromegaly group and the healthy volunteers were
matched with respect to age but the proportion of females
was higher in the healthy control group (p = 0.034). About
45.7% of the acromegalic patients had pathognomonic
acromegalic oral features like macroglossia, prognatism,
and/or malocclusion. Diabetes or prediabetes was
encountered in 11 of the acromegaly patients.

Table 1. Clinical characteristics and the gingival BMP levels of the study participants.
Acromegaly
patients (n = 35)

Healthy control
group(n = 22)

p

Age (years)

46.7 ± 10.2

42.4 ± 4.2

NS*

Sex (F/M)

21/14

19/3

0.034**

Acromegaly disease duration

6.87 ± 3.2

-

-

Diabetes/prediabetes mellitus

11 (31.4%)

-

-

Primary or secondary hypogonadism

6 (17.1%)

-

Secondary hypothyroidism
Typical acromegalic oral features
Macroglossia/prognathism/malocclusion
Chronic periodontitis (any degree) (n,%)

2 (5.7%)

-

-

16 (45.7 %)

-

-

16 (45.7%)

5(22.7%)

0.043**

Advanced chronic periodontitis (n,%)

2 (5.7 %)

1 (4.5%)

NS**

Chronic periodontitis (any degree) in females (n,%)

9 (42.8%)

4 (21.9%)

NS**

Chronic periodontitis (any degree) in males (n,%)

7 (50%)

1 (33.3%)

NS**

Gingival BMP2 (pg/mL)

33.5 ± 20.4

39.2 ± 17.4

NS*

Gingival BMP4 (pg/mL)

36.4 ± 26.4

29.9 ± 14.6

NS*

NS = nonsignificant, BMP2: Bone mophogenetic protein-1; BMP4: Bone morphogenetic protein-4. *Student’s t test,
** Chi Square test
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Hypogonadism was diagnosed in 6 of the acromegalics, 4 of
which were secondary and 2 were primary hypogonadism
cases. Secondary hypothyroidism was present in 2 of the
acromegalics, while there was no patient with primary
hypothyroidism. Frequency of chronic periodontitis was
higher in acromegalic patients (45.7% vs. 22.7%; p = 0.043).
Although mild-to-moderate degree of chronic periodontitis
was more frequent in acromegalics, advanced periodontitis
cases were similar in number in both groups (5.7% vs. 4.5%;
p > 0.05) (Table 1). In real life generally and in case of our
present study, females have better oral hygiene (as noted
from questionnaire about oral hygiene and frequency of
annual check-up and/or regular dental visits in our study).
Hence the predominance of females in the healthy control
group have biased the results of our study. Male abundance
and the frequent periodontitis in males in acromegalics
(50%) increased the total cases with periodontitis in the
acromegaly group in the present study. When the groups
were matched with sex, the females and males in both
groups of study participants revealed similar frequency of
periodontitis (Table 1). There was also no increase in the
frequency of any degree of periodontitis cases even in those
with robust manifestations of pathognomonic oral features
of acromegaly such as macroglossia, prognathism, and/
or malocclusion. Gingival BMP-2 and BMP-4 levels were
similar in the acromegaly and control groups (Table 1).
Plasma IGF-1, GH and IGFBP-3, and gingival BMP
levels according to the disease activity in the acromegalic
group of are given in Table 2. Both gingival BMP-2 and

BMP-4 levels were similar in those with active and inactive
acromegalics. Plasma GH, IGF-1, and IGFBP-3 levels were
statistically high, as expected, in those acromegalics with
active disease. There were 23 acromegalics with active
GH secretion with a median disease duration of 4.5 years
(interquartile range Q3-Q1 = 5.5 years). Median duration
of acromegaly was 8 years (interquartile range Q3-Q1
= 4 years) in those with inactive disease. The duration of
acromegaly was statistically longer in those with inactive
disease (p = 0.01) (Table 2). Total duration of disease
inactivity was minimum 6 months and maximum of about
3 years for these patients at the time of study enrollment.
Disease duration and duration of disease inactivity did not
correlate with the gingival BMP levels.
Frequency of chronic periodontitis and gingival BMP
levels were similar in acromegalics regardless of disease
activity at the time of study enrollment. Likewise, presence
of diabetes or prediabetes, nor the hypogonadism influenced
the periodontal tissue health in our patient population.
Table 3 gives the gingival BMP levels according to
periodontal tissue health. When those with and without
chronic periodontitis were subgrouped, gingival BMP2 levels were statistically lower in those participants with
chronic periodontitis then those without periodontitis (29.4
± 11.2 vs. 41.2 ± 23.2, respectively, p = 0.027). Gingival
BMP-4 levels were similar in those with and without
periodontitis.
When the acromegalics and healthy controls with and
without chronic periodontitis were analysed separately,

Table 2. Gingival BMP levels according to disease activity of the acromegalic group.
Acromegaly patients
with active disease
(high GH/IGF-1 levels)
(n = 23)

Acromegaly patients
with inactive disease
(normal GH/IGF-1 levels)
(n = 12)

p

GH (ng/mL)

7.4 ± 3.1

2.4 ± 0.2

0.003*

IGF-1 (ng/mL)

411.0 ± 129.5

245.9 ± 31.7

0.008*

IGFBP-3 (ng/mL)

2056.0 ± 393.7
Median :8
IQR: 4
4/12 (33.3%)

0.004*

Presence of diabetes/prediabetes

4178.3 ± 1086.8
Median 4.5
IQR: 5.5
5/23 (21.7%)

Presence of hypogonadism

4/23 (17.4%)

2/12 (16.6.%)

NS

Presence of typical oral features
(macroglossia/prognathism/malocclusion)

10/23 (43.4%)

6/12 (50%)

NS

Chronic periodontitis of any degree

10/23

6/12

NS

Gingival BMP2(pg/mL)

26.6 ± 14.7

40.3 ± 28.2

NS

Gingival BMP4(pg/mL)

37.7 ± 37.6

34.0 ± 14.7

NS

Disease duration (years)

0.01+
NS

NS = nonsignificant BMP1: Bone mophogenetic protein 1 (pg/mL); BMP2: Bone morphogenetic protein 2 (pg/mL);
GH: Growth hormone; IGF-1: Insulin like growth factor -1; IGFBP-3: Insulin like growth factor binding protein-3; IOR:
Interquartile ratio (Q3-Q1), *Student’s t test, ** Chi Square test, + Mann–Whitney U test.
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both the acromegalics and the healthy control group,
revealed similar gingival BMP-2 and BMP-4 levels.
Table 4 summarizes the relation of gingival BMP levels
with the periodontal tissue health status in acromegalics
and the control group. Causal relation between the
gingival BMP levels and periodontal tissue health status
was tested with one way ANOVA, which revealed a
significant difference between gingival BMP-2 levels
in those with different degrees of periodontal tissue
pathology (p = 0.025). When analyzed separately, gingival
BMP-2 levels revealed a causal relation with the degree of
periodontal pathology with borderline significance only
in patients with acromegaly (p = 0.057). As the gingival
BMP2 levels decreased, periodontal pathology tended to
advance to higher degrees in severity (Table 4 and Figure).
No significant correlation existed between gingival BMP-4
level and periodontal tissue pathology in the acromegalics.
Likewise, neither the gingival BMP-2 nor the BMP-4 levels

had been found to be correlated with the periodontal
pathology in the healthy controls (Table 4).
4. Discussion
In the previous studies exploring periodontal pathologies
in acromegaly, periodontitis was found to be unexpectedly
rare in these patients (6,12). In our present study,
however, when both males and females were analysed
together, periodontitis was found to be more frequent
in the acromegaly group. Most probably, the female
predominance in the control group might have biased
the result. After matching the study participants with
respect to sex, we found a similar frequency of chronic
periodontitis in the acromegaly and the control groups.
Although the typical oral manifestations like macroglossia,
prognathism, and malocclusion were encountered in
almost half of our acromegaly patients in the present
study, the occurence, frequency, and grade of periodontitis

Table 3. Gingival BMP levels in subgroups of study participants.
Participants with chronic
periodontitis (n = 21)

Participitants without
periodontitis (n = 36)

p

Gingival BMP2 (pg/mL)

29.4 ± 11.2

41.2 ± 23.2

0.027*

Gingival BMP4 (pg/mL)

37.3 ± 5.8

30.9 ± 6.7

NS

Acromegaly group:

Acromegaly patients with
chronic periodontitis (n = 16)

Acromegaly patients without
chronic periodontitis (n = 19)

Gingival BMP2 (pg/mL)

28.1 ± 11.6

39.9 ± 26.8

NS

Gingival BMP4 (pg/mL)

41.4 ± 34.2

31.86 ±17.9

NS

Control group:

Healthy controls with chronic
periodontitis (n = 5)

Healthy controls without
chronic periodontitis (n = 17)

Gingival BMP2 (pg/mL)

33.5 ± 9.9

40.9 ± 9.9

NS

Gingival BMP4 (pg/mL)

24.1 ± 10.7

31.6 ± 15.4

NS

*Student’s t test.
Table 4. One way ANOVA test results of the effect of gingival BMP2 levels on the severity of periodontitis in
acromegaly patients and the healthy controls.
All participants (n = 57)

Mean Gingival BMP2 levels (pg/mL)

No periodontitis

Mild to moderate
periodontits

Severe
periodontitis

p

41.3 ± 22.2

29.3 ± 9.4

20.8 ± 8.2

0.025

41.7 ± 25.6

27.7 ± 8.6

17.7 ± 5.1

0.057

40.9 ± 18.9

33.5 ± 11.4

33.2

NS

Acromegaly patients (n = 35)
Mean Gingival BMP2 levels (pg/mL)
Healthy controls (n = 22)
Mean Gingival BMP2 levels (pg/mL)
NS: nonsignificant
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Figure. Mean BMP2 levels in groups of different periodontitis severity in the acromegalics. Degree
of periodontitis: 0: No periodontitis; 1-2: Mild to moderate periodontits; 3: Severe periodontitis.

were not increased. In accordance with this finding, the
frequency of severe-advanced periodontitis was not
increased in our acromegaly group and was similar to the
control group. In a recent study of Ozdemir et al., lower
occurrence of advanced periodontitis was encountered in
the acromegaly patients (13).
In our present study, we hypothesized that excess GH/
IGF-1 affects bone remodelling in periodontal tissue via
increasing the local BMP levels. This unexpected finding
of the preservation of periodontal tissue in such a chronic
disease with typical and pathognomonic derangements in
oral tissue and anatomy can be explained by the long-term
stimulation of local periodontal ligament cells with GH/IGF1 and local increase of BMP family of proteins secondarily
(8). In our study, although local BMP levels were similar in
healthy and acromegalic participants, mean gingival BMP-2
levels differed according to the severity of periodontal tissue
pathology. As the local gingival BMP2 levels increased,
periodontitis severity decreased in the acromegaly patients.
Such a relation with gingival BMP-2 levels was not seen in
the healthy participants. This finding supports the suggested
local protective and/or regenerative role of periodontal BMP2 in acromegalic patients. We did not find a similar effect of
BMP-4 levels on periodontal tissue health. Both BMP-2 and
BMP-4 are the members of same family; however, they may
have different effects on periodontal tissue (14).

In our present study, although the gingival BMP2 levels
tend to be higher in those with healthier periodontal tissue,
gingival BMP-2 and BMP-4 levels were similar in the
active and inactive acromegaly patients. Total acromegaly
disease duration and duration of the inactive acromegaly
period did not show any effect on the gingival BMP levels
in the present study. However, this finding should be
interpreted cautiously. Since acromegaly has a significant
diagnostic delay in almost all patients (15), the duration of
disease calculated from the time of biochemical diagnosis
usually does not reflect exactly the actual cummulative
exposure of tissues to the GH excess. Further prospective
studies evaluating the periodontal status of patients with
acromegaly may extend our knowledge on this issue.
The relatively small sample size and the cross-sectional
nature of our study are its major limitations. Considering
this, and the fact that acromegaly is a very rare disease
with a prevalence of 50–70 cases per million, it is usually
hard to evaluate large numbers of cases in a single centre.
We recruited the acromegaly patients and controls that
we could reach from our acromegaly pool of hospital and
get informed consent. We are also aware of the possible
selection bias both in acromegalics and control subjects,
which may not truly reflect the reality and thus, does not
allow to make solid conclusions about the protective role
of local gingival BMP levels in acromegaly patients.
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In conclusion, acromegaly is a disease with an
unexpectedly low frequency of severe to advanced
periodontal pathology, irrespective of the long disease
duration and pathognomonic oral manifestations.
Although we could not find any differences in local
gingival BMP-2 and BMP-4 levels between patients in
the acromegaly and control groups, the unexpectedly
low frequency of severe periodontitis and the finding of
increasing levels of gingival BMP-2 levels as the degree
of periodontal tissue problem decreases in acromegalics,

suggested a protective role for BMP-2 in acromegalics. As
the gingival BMP2 levels decreased, periodontal pathology
tended to advance to higher degrees in severity. To the
best of our knowledge, this is the first study evaluating
BMP-2 and -4 levels in the gingival fluid of patients with
acromegaly. Our study is a pilot study and forms basis for
further studies with larger sample sizes to evaluate the
local regenerative and/or destructive processes and factors
influencing the periodontal tissue biology in acromegaly
patients.
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